Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Smoking cessation

Oral mucosal membranes provide a port for systemic therapy as weU. Nitroglycerin sublingual tablets (Nitrostat) abort acute mgina attacks methyl-testosterone [58-18-4] buccal tablets (Android 5) are indicated for testosterone [58-22-0] replacement therapy (39) md nicotine [54-11-5] gum (Nicorette) aids in smoking cessation. [Pg.141]

Despite the limitations imposed by the physiology of the skin, several marketed controUed release transdermal dmg dehvery systems are available in the United States for example, scopolamine [51-34-3] for the treatment of motion sickness, nitroglycerin [55-63-0] for angina, estradiol [50-28-2] for the rehef of postmenopausal symptoms and osteoporosis, clonidine [4205-90-7] for the treatment of hypertension, fentanyl [437-38-7] as an analgesic, and nicotine [54-11-5] as an aid to smoking cessation. These systems are designed to dehver dmg for periods of one to seven days. [Pg.226]

Classic risk factors of atherosclerosis must first and foremost be fought with lifestyle interventions such as diet, physical activity, and smoking cessation. Indeed, and although it effectively relieves angina, simply... [Pg.226]

Usually, it takes years of toxin exposure to cause the pathological alterations seen in COPD. In most cases, the disease is already well-progressed when COPD is diagnosed. Reversal of established chronic inflammatory disease is always extremely difficult to achieve and at present healing of COPD is impossible. Smoking cessation is the single most effective and cost-effective... [Pg.364]

Jorenby DE, Leischow SJ, Nides MA, et al A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Eng J Med 340 685— 691, 1999... [Pg.179]

Patients who use the lozenge for smoking cessation should use one lozenge every 1-2 hours for the first 2— weeks, decreasing the interval to every 2-4 hours thereafter. Adverse effects that are common with the nicotine lozenge include heartburn, hiccups, and nausea (Shiffman et al. 2002). Because the product contains phenylalanine, the lozenge should not be used for smoking cessation by individuals with phenylketonuria. [Pg.318]

Transdermal nicotine (i.e., the nicotine patch) is also available over the counter for smoking cessation. This form of nicotine dehvery may be espe-... [Pg.318]

Nicotine nasal spray delivers nicotine through the nasal mucosa. One advantage of nicotine nasal spray is that it relieves tobacco cravings quickly. One study found that nicotine nasal spray was 2.6 times more likely to produce smoking cessation, compared with placebo, at 1 year (Sutherland et al. 1992). The active spray was also the most beneficial among highly dependent smokers (Sutherland et al. 1992). [Pg.319]

As previously discussed, currently available NRT products typically double the rate of smoking cessation, relative to placebo. It has been suggested that one... [Pg.320]

Use in smoking cessation in psychiatric or substance abuse populations. [Pg.324]

Nortriptyline. Nortriptyhne, a tricychc antidepressant, has been shown in double-blind, placebo-controlled randomized trials to be superior to placebo for smoking cessation (Prochazka et al. 1998). Nortriptyline appears to have efficacy comparable to that of bupropion for smoking cessation (Hall et al. 2002). The efficacy of this agent may be improved with more intensive behavioral therapies (Hall et al. 1998). Nortriptyline s mechanism of action is thought to relate to its noradrenergic and serotonergic reuptake blockade, because these two neurotransmitters have been implicated in the neurobiology of nicotine dependence. Side effects of nortiptyline are typical of tricyclic antidepressants and include dry mouth, blurred vision, constipation, and orthostatic hypotension. Nortriptyline appears to have some utility for smokers with a past history of major depression, and it can be recommended as a second-... [Pg.325]

Rates of smoking among patients with bipolar disorders and anxiety disorders (e.g., posttraumatic stress disorder, panic disorder) are also higher than those in the general population (Lasser et al. 2000), but there has been htde smdy of the factors associated with motivation to quit smoking or of smoking cessation interventions in these patient groups. [Pg.332]

General precautions for each medication that has been used for smoking cessation are listed in the sections describing each medication. All FDA-approved first-line medications for smoking cessation have a relatively good safety profile. Consensus opinions on the safety of the various medications for persons with cardiovascular disease, other medical conditions, and pregnancy are beyond the scope of this chapter but can be found elsewhere (Society for Research on Nicotine and Tobacco 2003). [Pg.332]


See other pages where Smoking cessation is mentioned: [Pg.89]    [Pg.523]    [Pg.144]    [Pg.227]    [Pg.854]    [Pg.1043]    [Pg.285]    [Pg.173]    [Pg.316]    [Pg.317]    [Pg.317]    [Pg.319]    [Pg.320]    [Pg.320]    [Pg.321]    [Pg.322]    [Pg.323]    [Pg.323]    [Pg.324]    [Pg.324]    [Pg.324]    [Pg.325]    [Pg.326]    [Pg.327]    [Pg.327]    [Pg.327]    [Pg.328]    [Pg.328]    [Pg.329]    [Pg.329]    [Pg.329]    [Pg.330]    [Pg.331]    [Pg.331]    [Pg.331]    [Pg.332]    [Pg.333]    [Pg.333]   
See also in sourсe #XX -- [ Pg.309 ]

See also in sourсe #XX -- [ Pg.17 , Pg.541 , Pg.541 , Pg.542 , Pg.1301 , Pg.1324 ]

See also in sourсe #XX -- [ Pg.454 ]

See also in sourсe #XX -- [ Pg.835 , Pg.836 , Pg.837 , Pg.924 ]

See also in sourсe #XX -- [ Pg.114 , Pg.118 , Pg.123 , Pg.127 , Pg.129 , Pg.241 , Pg.245 ]

See also in sourсe #XX -- [ Pg.59 , Pg.164 ]

See also in sourсe #XX -- [ Pg.347 ]

See also in sourсe #XX -- [ Pg.34 ]

See also in sourсe #XX -- [ Pg.518 , Pg.520 , Pg.521 , Pg.527 ]

See also in sourсe #XX -- [ Pg.356 ]

See also in sourсe #XX -- [ Pg.518 ]

See also in sourсe #XX -- [ Pg.226 ]

See also in sourсe #XX -- [ Pg.138 ]

See also in sourсe #XX -- [ Pg.44 , Pg.70 , Pg.72 , Pg.125 , Pg.185 ]

See also in sourсe #XX -- [ Pg.835 , Pg.836 , Pg.837 , Pg.924 ]

See also in sourсe #XX -- [ Pg.588 ]

See also in sourсe #XX -- [ Pg.1199 , Pg.1200 , Pg.1201 , Pg.1201 , Pg.1202 , Pg.1203 , Pg.1204 ]

See also in sourсe #XX -- [ Pg.458 ]

See also in sourсe #XX -- [ Pg.458 ]

See also in sourсe #XX -- [ Pg.111 , Pg.128 , Pg.399 , Pg.413 ]

See also in sourсe #XX -- [ Pg.64 , Pg.159 ]

See also in sourсe #XX -- [ Pg.480 , Pg.731 ]

See also in sourсe #XX -- [ Pg.422 , Pg.517 ]




SEARCH



Aids for Smoking Cessation

Bupropion in smoking cessation

Cessation

Chronic obstructive pulmonary disease smoking cessation

Cigarette smoke cessation drugs

Cognitive therapy smoking cessation

Myocardial infarction smoking cessation

Nicotine in smoking cessation

Nortriptyline in smoking cessation

Pregnancy smoking cessation

Smoking cessation aids

Smoking cessation blood pressure lowering

Smoking cessation bupropion

Smoking cessation clonidine

Smoking cessation drugs

Smoking cessation health benefits

Smoking cessation prescription drugs

Smoking cessation support groups

Smoking cessation withdrawal symptoms

Smoking cessation, varenicline treatment

Smoking-cessation service

Tobacco smoking cessation aids

© 2024 chempedia.info